Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Oncologisch Centrum GZA - Location St. Augustinus, Wilrijk

Universitaire Ziekenhuizen UZ Gasthuisberg, Leuven

Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum Belgyogyaszati Intezet,, Debrecen

Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly, Kaposvár

Universitair Ziekenhuis Gent, Ghent

Charite Campus Mitte, Berlin

New York Medical College, Hawthorne

Charite Berlin-Campus Virchow-Klinikum, Berlin

CMSA Medical Lab, State College

Carlisle Regional Medical Center Lab, Carlisle

Lewistown Hospital, Lewistown

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

Park Nicollet Frauenshuh Cancer Center, Saint Louis Park

Rush University Medical Center, Chicago

Barnes-Jewish Hospital, St Louis

Washington University School of Medicine, St Louis

Facey Medical Group, Mission Hills

Providence Holy Cross, Mission Hills

Loma Linda University Cancer Center #5, Loma Linda

Loma Linda University Medical Center, Loma Linda

University of Alabama Birmingham, Birmingham

University of Alabama at Birmingham, Birmingham

Loma Linda University Cancer Center, Loma Linda

Hackensack University Medical Center, Hackensack

John Theurer Cancer Center, Hackensack

Quest Diagnostics, Allentown

Penn State Milton S. Hershey medical Center, Hershey

Fox Chase Cancer Center, Philadelphia

University of Texas, MD Anderson Cancer Center, Houston

The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T.

National Hp. Org. Kyushu Medical Center, Fukuoka

National Cancer Center Hospital East, Kashiwa

National Cancer Center Hospital, Chuo-ku

EPMint Co., Ltd, Aichi

Nagoya Daini Red Cross Hospital, Aichi

National Hospital Organization Kyushu Cancer Center, Fukuoka

Tokai University Hospital, Kanagawa

Cancer Inst. Hp. of Japanese Foundation for Cancer Research, Tokyo

Erasmus Medisch Centrum, Rotterdam

Erasmus MC Apotheek, Rotterdam

Singapore General Hospital, Singapore

Samsung Medical Center, Seoul